An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of...
A study from scientists at The Scripps Research Institute (TSRI) recently found that a vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of...